A new combination of substances, already in use individually for treating various human pathologies, was administered intravenously to 11 neurologically normal patients and 3 patients with stroke or transient ischemic attack which occurred at least 1 week prior to treatment. A total of 22 such infusions were given beginning with October 2014 with good results and minor side effects (restless first night after infusion). The combination was individually adjusted and consisted of: deproteinated calf serum, dimethylsulfoxide, oxytocin, glutathion, dopamine, vitamins B (group) and C; it had positive and notable effects both in neurologically normal and in patients with neurological pathology (post-stroke).